GFM Network News


Bayer books second-quarter loss after settlement

Frankfurt | Reuters — German drugs and pesticides group Bayer reported a 9.5 billion-euro (C$14.86 billion) net loss for its second quarter, following a US$10.9 billion settlement of U.S. lawsuits claiming that its Roundup herbicide caused cancer. The charges stemmed mainly from agreements which attempted to wrap up legal disputes inherited with its US$63 billion

Comment: Bayer settlement aimed at getting back to business

Lawsuit was putting the safety of glyphosate in the legal realm, not the scientific

Imagine buying a house that you’ve always had your eye on only to learn that some seemingly fixable flaws were actually masking a much more deeply rooted problem. That’s the situation Bayer CropScience found itself in shortly after sealing its US$63-billion takeover bid for rival life science company Monsanto in 2018. It became clear early


Bayer launches carbon capture pilot for U.S., Brazilian farmers

Chem and seed firm expects to expand plan to other countries

Chicago | Reuters — Bayer launched a pilot program in the United States and Brazil on Tuesday that will pay farmers for capturing carbon in cropland soils, making it the latest agriculture company to capitalize on environmental initiatives. The company seeks to enroll about 1,200 row crop growers in its Bayer Carbon Initiative in the

Bayer loses California appeal of Roundup verdict

Damages payable to plaintiff are further reduced

Reuters — Bayer AG failed to persuade a California appeals court to overturn a verdict favouring a school groundskeeper who claimed its Roundup weed killer caused his cancer but reduced the amount of damages by 74 per cent, to US$20.5 million. The decision by the California Court of Appeal came after a San Francisco jury

Elanco Animal Health wins U.S. approval to buy Bayer unit

Elanco to shed cattle pour-on brand, others for approval

Washington | Reuters — Elanco Animal Health has won U.S. antitrust approval to buy Bayer’s animal health business on condition that it sell assets to treat three ailments, two in dogs and one in cattle, the Federal Trade Commission said on Wednesday. The deal was valued at $7.6 billion when it was announced in August


Elanco forgoes Canadian poultry insecticide rights for Bayer deal

Reuters — Elanco Animal Health has decided against acquiring Bayer’s Canadian distribution rights to several poultry insecticides, Canada’s Competition Bureau said on Tuesday, as it looks to complete a $7.6-billion deal. The U.S.-based company will also divest its canine ear infection treatment product Osurnia and Bayer’s feline dewormer Profender to address competition concerns about its

Bayer puts Roundup future claims settlement on hold

Judge questions proposal for third-party scientists to rule on chemical's carcinogenicity

Frankfurt | Reuters — Bayer was forced on Wednesday to delay part of a proposed settlement of allegations that its widely used herbicide Roundup caused cancer after a U.S. judge questioned its plan to deal with future claims. The German company said that lawyers representing those preparing a class action had withdrawn a request for

Bayer, Corteva among companies stepping off Facebook

Major firms pledge to pause advertising for July

A couple of major players in the agriculture sector are on an expanding list of major companies pausing advertising on Facebook for the month of July in pursuit of policy changes at the U.S.-based social media giant. Bayer and Corteva Agriscience recently announced they have joined the #stophateforprofit campaign, backed by organizations including the Anti-Defamation


Investors pile into Bayer bond to pay settlement charges

Amsterdam | Reuters — Investors piled into a Bayer bond on Wednesday that will help pay for a long-negotiated settlement of U.S. lawsuits claiming its widely-used herbicide Roundup caused cancer. Demand for the four-tranche bond sale, whose proceeds will include the litigation payments, exceeded 17.5 billion euros, nearly three times the six billion euros (C$9.15

U.S. settlements not expected to change availability, labels for glyphosate, dicamba

Bayer to pay up to US$12 billion to resolve ag chem, PCB claims; company is "not contemplating" a Canadian glyphosate settlement

Updated, June 25 — Farmers in Canada, the U.S. and elsewhere shouldn’t expect any changes to availability or label directions for Bayer’s stable of glyphosate and dicamba herbicides, coming out of a massive settlement for thousands of lawsuits, the company says. The German company announced Wednesday it expects to spend up to $12 billion in